Fenretinide (4-HPR): A Preventive Chance for Women at Genetic and Familial Risk?

por Cazzaniga, Massimiliano, Varricchio, Clara, Montefrancesco, Chiara, Feroce, Irene, Guerrieri-Gonzaga, Aliana
Publicado 2012

Low-Dose Aspirin in High-Risk Individuals With Screen-Detected Subsolid Lung Nodules: A Randomized Phase II Trial

por Bonanni, Bernardo, Serrano, Davide, Maisonneuve, Patrick, Veronesi, Giulia, Johansson, Harriet, Aristarco, Valentina, Varricchio, Clara, Cazzaniga, Massimiliano, Lazzeroni, Matteo, Rampinelli, Cristiano, Bellomi, Massimo, Vecchi, Manuela, Spaggiari, Lorenzo, Vornik, Lana, Brown, Powel H, Beavers, Therese, Guerrieri-Gonzaga, Aliana, Szabo, Eva
Publicado 2020

A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer

por Serrano, Davide, Lazzeroni, Matteo, Gandini, Sara, Macis, Debora, Johansson, Harriet, Gjerde, Jennifer, Lien, Ernst, Feroce, Irene, Pruneri, Giancarlo, Sandri, Maria Teresa, Bassi, Fabio, Brenelli, Fabricio, Luini, Alberto, Cazzaniga, Massimiliano, Varricchio, Clara, Guerrieri-Gonzaga, Aliana, DeCensi, Andrea, Bonanni, Bernardo
Publicado 2013